Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing. Shareholders will review and vote on multiple special resolutions, chiefly focusing on the adoption of the Restricted Share Unit (RSU) Scheme (H Share) and a Scheme Mandate Limit.

According to the announcement, the proposed RSU Scheme aims to attract and retain employees deemed key to the company’s long-term growth, allowing eligible participants to receive RSUs under a total issue cap of up to 5% of the company’s outstanding shares (excluding any treasury shares) as of the adoption date. The meeting will also consider related authorizations for directors to grant share awards and amend the Articles of Association if new shares are issued pursuant to the RSU Scheme.

The register of members for Lepu Biopharma’s H shares will be closed for transfer from December 15 to December 18, 2025, inclusive. Shareholders intending to appoint a proxy should submit the required forms at least 24 hours before the meeting. The full details and proxy forms are available on the Hong Kong Stock Exchange and the company’s website.